Chemplast Sanmar Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2025.
CHEMPLASTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 1.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chemplast Sanmar's board approved audited standalone and consolidated results for Q4 and FY25 (ended March 31, 2025). Standalone revenue from operations jumped 44% year-on-year to Rs 2,387.61 crore, while consolidated revenue grew nearly 11% to Rs 4,346.07 crore. The company, however, remained loss-making at the bottom line: standalone loss after tax narrowed to Rs 52.30 crore (from Rs 65.57 crore) and consolidated loss narrowed to Rs 48.52 crore (from Rs 67.14 crore). Operating cash flow turned sharply positive, with standalone OCF at Rs 218.81 crore and consolidated OCF at Rs 171.67 crore, both reversing prior year outflows. Statutory auditor BSR & Co LLP issued an unmodified (clean) opinion on the results. The board did not recommend any dividend for FY25. It also appointed Mr. Vikram Taranath Hosangady as a Non-Executive Independent Director for five years and B Ravi and Associates as Secretarial Auditor for FY26–FY30.
Strong top-line growth and narrowing losses, plus a swing to positive operating cash flow, are encouraging signs for shareholders, but the company is still loss-making and has skipped dividend, so near-term shareholder returns remain limited. The clean audit opinion and stable board reinforce governance confidence, though investors will look for the company to cross into profitability.